“Should I take tirzepatide or semaglutide?” is one of the most common questions at a medical weight-loss consultation. Both are weekly injectable medications, both reduce appetite, and both have strong research behind them. They are not identical, though, and a direct comparison helps you ask better questions.
How each medication works
Semaglutide acts on one hormone pathway, the GLP-1 receptor. It helps you feel full sooner, reduces appetite, and slows stomach emptying. Tirzepatide acts on two pathways: GLP-1 and GIP. The GIP pathway is also involved in appetite and metabolism, and researchers believe the dual action contributes to tirzepatide’s results.
Both are started at a low dose and increased gradually. That slow increase gives the digestive system time to adjust and lets the provider find a dose that balances results with tolerability.
What the head-to-head trial found
The SURMOUNT-5 trial, published in The New England Journal of Medicine in 2025, compared the two directly in 751 adults with obesity or overweight without diabetes. Participants used the highest dose they could tolerate. After 72 weeks, average weight loss was about 20.2 percent of body weight with tirzepatide and 13.7 percent with semaglutide. Waist reduction was also larger with tirzepatide.
Those are averages. Some people on semaglutide lost more than some people on tirzepatide, and individual response varies widely. The trial was open-label and sponsored by tirzepatide’s manufacturer, which is worth knowing when you read headlines about it. It is still one of the clearest comparisons available.
Side effects are similar in type
Both medications most often cause nausea, diarrhea, constipation, vomiting, and reduced appetite, usually while the dose is increasing. In SURMOUNT-5, stopping treatment because of gastrointestinal side effects was somewhat more common with semaglutide. Your own experience may differ, and many side effects ease with time, slower dose increases, and changes to meal size.
Both carry the same major warnings, including the thyroid C-cell tumor warning, pancreatitis, gallbladder disease, and dehydration from severe vomiting or diarrhea. Both slow stomach emptying, which can affect how other oral medications are absorbed. Tell your provider about every medication you take, including birth control pills.
Why a provider might choose one over the other
A higher average weight loss does not automatically make tirzepatide the right first choice for everyone. Providers weigh:
- Your health history and current medications
- How you tolerated any previous GLP-1 medication
- Your weight-loss goal and how quickly change is appropriate
- Other health goals, such as blood sugar or cardiovascular risk
- Availability and total cost of treatment
- Your preference after hearing the trade-offs
Someone doing well on semaglutide with manageable side effects may have no reason to switch. Someone who plateaued or struggled with side effects may want to discuss a change.
Switching from one to the other
Switching is common and can be reasonable, but it is not a direct swap. Doses do not convert one to one, and the new medication usually starts at its own lower dose. Expect a short adjustment period with possible side effects. Do not take both at the same time or change your dose yourself.
Results depend on more than the medication
Neither medication works in isolation. Protein intake, strength training, sleep, alcohol, and steady follow-up all influence how much weight you lose and how much muscle you keep. Rapid weight loss can also bring hair shedding or changes in facial volume, which are worth discussing early.
How Harmony approaches the choice
Harmony Med Spa’s medical weight-loss program in Sarasota begins with a consultation that reviews your history, goals, and current medications. Regular weigh-ins let the provider adjust dosing and watch for side effects. Ask which medications are currently offered, how dosing is increased, and what the total program cost includes. The best medication is the one that is safe for you, that you can tolerate, and that fits a plan you can keep up.
Frequently asked questions
Is tirzepatide stronger than semaglutide?
In the SURMOUNT-5 head-to-head trial, average weight loss at 72 weeks was greater with tirzepatide (about 20%) than semaglutide (about 14%). Individual results vary, and the best choice depends on your health and tolerance.
Do they have the same side effects?
They share similar gastrointestinal side effects and the same major warnings. Tolerance differs from person to person.
Can I switch from semaglutide to tirzepatide?
Often, yes, under provider supervision. The new medication usually starts at its own dose rather than an equivalent of your old one.
Which one works faster?
Both increase gradually over several months. Speed depends on dose increases, tolerance, and lifestyle factors more than on the medication name alone.
Will I regain weight if I stop?
Weight regain after stopping is common with both. Discuss a long-term plan, including nutrition and strength training, before you start.
Which does Harmony offer?
Ask the Harmony team which GLP-1 medications the program currently offers and how the choice is made for you.
Sources and further reading
Aronne LJ et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5), NEJM 2025: https://www.nejm.org/doi/full/10.1056/NEJMoa2416394
ACC journal scan of SURMOUNT-5: https://www.acc.org/latest-in-cardiology/journal-scans/2025/07/10/09/09/surmount-5
Continue exploring
Personalized care in Sarasota
Ready to discuss your options?
A consultation connects the information in this guide to your health history, goals, timeline, and budget.
Compare GLP-1 options with a provider